| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2123926 | European Journal of Cancer | 2009 | 10 Pages |
Abstract
Imatinib was tolerated well, but failed to show efficacy according to standard criteria in paediatric malignancies expressing KIT or PDGFR.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Birgit Geoerger, Bruce Morland, Anna Ndiaye, Francois Doz, Gabriel Kalifa, Anne Geoffray, Fabienne Pichon, Didier Frappaz, Etienne Chatelut, Paule Opolon, Sharon Hain, Francoise Boderet, Jacques Bosq, Jean-Francois Emile, Marie-Cecile Le Deley,